Serlopitant

Unassigned

New Medicines

Chronic pruritus, any cause

Information

New molecular entity
Menlo Therapeutics
Menlo Therapeutics

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

Neurokinin-1 (NK-1) receptor antagonist
Chronic pruritus is common, and can lead to seriously impaired quality of life; it may be associated with many diseases both local and systemic and there are few specific and effective treatments [1].
Chronic pruritus, any cause
Oral